Glycated hemoglobin News and Research

RSS
Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Texas Health Dallas offers heart and vascular screening program for women

Texas Health Dallas offers heart and vascular screening program for women

Tubing-Free Insulin Pump System improves glycemic control in diabetic patients

Tubing-Free Insulin Pump System improves glycemic control in diabetic patients

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reports consolidated group sales of €1,032.8M for 2009

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

OSA adversely affects glucose control in patients with type 2 diabetes

OSA adversely affects glucose control in patients with type 2 diabetes

American Clinical Laboratory Association lauds ADA's recommendation of HbA1C test for diabetes

American Clinical Laboratory Association lauds ADA's recommendation of HbA1C test for diabetes

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Headline results from first phase III study of Balaglitazone announced

Headline results from first phase III study of Balaglitazone announced

ADA recommends the A1C test for diabetes screening and diagnosis

ADA recommends the A1C test for diabetes screening and diagnosis

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Physicians favor agents that can reduce HbA1c levels by 2% in diabetes patients

Physicians favor agents that can reduce HbA1c levels by 2% in diabetes patients

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients